{"id":"placebo-ip","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4650310","moleculeType":"Small molecule","molecularWeight":"271.32"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Placebo is an inactive substance used as a comparator in randomized controlled trials to assess the efficacy of an investigational drug by isolating the true pharmacological effect from placebo response and natural disease progression. It has no molecular target or mechanism of action.","oneSentence":"Placebo produces no pharmacological effect and serves as an inert control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:40.550Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07332091","phase":"PHASE2","title":"Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2026-01-22","conditions":"Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis","enrollment":84},{"nctId":"NCT06425159","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures","status":"TERMINATED","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-06-20","conditions":"Generalized Epilepsy","enrollment":27},{"nctId":"NCT04774159","phase":"PHASE3","title":"Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2021-05-06","conditions":"Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation","enrollment":6150},{"nctId":"NCT05430230","phase":"PHASE4","title":"Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2022-08-24","conditions":"Osteoarthritis, Knee","enrollment":20},{"nctId":"NCT06309966","phase":"PHASE2, PHASE3","title":"Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-05-13","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT06132893","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-03-14","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT04877691","phase":"PHASE3","title":"Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-08","conditions":"Systemic Lupus Erythematosus","enrollment":367},{"nctId":"NCT05831449","phase":"PHASE3","title":"CPL-01 in the Management of Postoperative Pain After Bunionectomy","status":"COMPLETED","sponsor":"Cali Pharmaceuticals LLC","startDate":"2023-05-22","conditions":"Bunion","enrollment":616},{"nctId":"NCT07444762","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2025-04-21","conditions":"Primary Hypercholesterolemia, Mixed Dyslipidemia","enrollment":184},{"nctId":"NCT07453069","phase":"PHASE2","title":"Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle","status":"NOT_YET_RECRUITING","sponsor":"Freya Biosciences ApS","startDate":"2026-04-15","conditions":"Vaginal Dysbiosis","enrollment":30},{"nctId":"NCT06714006","phase":"PHASE1","title":"Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003","status":"RECRUITING","sponsor":"PYC Therapeutics","startDate":"2025-04-07","conditions":"Autosomal Dominant Polycystic Kidney Disease (ADPKD)","enrollment":116},{"nctId":"NCT05677113","phase":"PHASE2","title":"A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-01","conditions":"Colorectal Cancer, Liver Metastases","enrollment":115},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT06195072","phase":"PHASE2","title":"Platform Clinical Study for Conquering Scleroderma","status":"RECRUITING","sponsor":"Scleroderma Research Foundation, Inc.","startDate":"2024-04-15","conditions":"Interstitial Lung Disease Due to Systemic Disease, Scleroderma","enrollment":400},{"nctId":"NCT05897385","phase":"NA","title":"Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2023-08-22","conditions":"Postoperative Pain, Gynecologic Disease, Local Anesthetic Systemic Toxicity","enrollment":112},{"nctId":"NCT07262268","phase":"PHASE1","title":"A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia","status":"ENROLLING_BY_INVITATION","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2026-01-15","conditions":"Familial Erythromelalgia","enrollment":5},{"nctId":"NCT06976268","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2025-05-28","conditions":"Parkinson Disease","enrollment":550},{"nctId":"NCT07299851","phase":"NA","title":"Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-10-01","conditions":"Fracture Femur, Fracture Tibia","enrollment":100},{"nctId":"NCT05948592","phase":"PHASE2","title":"Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection","status":"COMPLETED","sponsor":"Technophage, SA","startDate":"2023-11-08","conditions":"Diabetic Foot Infection","enrollment":76},{"nctId":"NCT06349083","phase":"PHASE2","title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-08-26","conditions":"Alcohol Use Disorder","enrollment":200},{"nctId":"NCT07268495","phase":"NA","title":"The Impact of Intraperitoneal Spray Combined With Intravenous Lidocaine on Postoperative Pain After Myomectomy","status":"RECRUITING","sponsor":"General Hospital of Ningxia Medical University","startDate":"2024-08-01","conditions":"Postoperative Pain","enrollment":100},{"nctId":"NCT07250594","phase":"PHASE2","title":"A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma","status":"NOT_YET_RECRUITING","sponsor":"Advagene Biopharma Co. Ltd.","startDate":"2025-12","conditions":"Eosinophilic Asthma","enrollment":126},{"nctId":"NCT04760353","phase":"NA","title":"The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"University Hospital Rijeka","startDate":"2021-11-10","conditions":"IBS - Irritable Bowel Syndrome, Obesity","enrollment":80},{"nctId":"NCT06562114","phase":"PHASE1","title":"A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment","status":"COMPLETED","sponsor":"Merry Life Biomedical Co., Ltd.","startDate":"2024-07-11","conditions":"Healthy","enrollment":72},{"nctId":"NCT03915769","phase":"PHASE3","title":"To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Celgene","startDate":"2019-06-03","conditions":"Colitis, Ulcerative","enrollment":198},{"nctId":"NCT05358821","phase":"PHASE2","title":"28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease","status":"COMPLETED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2022-05-26","conditions":"Huntington Disease","enrollment":69},{"nctId":"NCT06963411","phase":"PHASE1","title":"Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Kokua Pharma Inc.","startDate":"2025-05-09","conditions":"Acute Allergic Reaction, Anaphylaxis","enrollment":16},{"nctId":"NCT07011797","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corxel Pharmaceuticals","startDate":"2025-06-17","conditions":"Obesity","enrollment":250},{"nctId":"NCT06855745","phase":"PHASE2","title":"Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.","status":"RECRUITING","sponsor":"Alphyn Biologics","startDate":"2025-03-25","conditions":"Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis","enrollment":72},{"nctId":"NCT06770933","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01","status":"RECRUITING","sponsor":"Vantage Biosciences Ltd","startDate":"2025-02-11","conditions":"Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy","enrollment":100},{"nctId":"NCT04721691","phase":"PHASE1","title":"Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2021-03-10","conditions":"Electrical Status Epilepticus of Slow-Wave Sleep","enrollment":16},{"nctId":"NCT05835206","phase":"PHASE2","title":"Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-04-25","conditions":"Multi-drug Resistant Organism","enrollment":40},{"nctId":"NCT06272747","phase":"PHASE1","title":"Study of XH-S003 in Healthy Volunteers","status":"COMPLETED","sponsor":"S-INFINITY Pharmaceuticals Co., Ltd","startDate":"2023-07-10","conditions":"Healthy Adults","enrollment":36},{"nctId":"NCT06903611","phase":"PHASE3","title":"Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Cambium Bio Limited","startDate":"2025-09-30","conditions":"Dry Eye Disease, Dry Eye, Dry Eyes Chronic","enrollment":400},{"nctId":"NCT05733364","phase":"NA","title":"Effect of 4 Weeks Supplementation of a Combination of Vitamin Bs and Taurine on Mental Performance in Healthy Adults","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2023-03-08","conditions":"Healthy","enrollment":45},{"nctId":"NCT06559618","phase":"PHASE1","title":"Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria","status":"RECRUITING","sponsor":"Barbara Wells Trautner","startDate":"2025-02-03","conditions":"Bacteriuria, Spinal Cord Injuries, Asymptomatic Bacteriuria","enrollment":30},{"nctId":"NCT06859853","phase":"PHASE1","title":"A Study to Evaluate MWN109 Injection in Healthy Subjects","status":"RECRUITING","sponsor":"Shanghai Minwei Biotechnology Co., Ltd","startDate":"2025-03-17","conditions":"Overweight or Obese","enrollment":72},{"nctId":"NCT05904717","phase":"PHASE2","title":"Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Syntara","startDate":"2023-11-08","conditions":"REM Sleep Behavior Disorder","enrollment":40},{"nctId":"NCT05433181","phase":"PHASE1, PHASE2","title":"ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2025-02","conditions":"SARS-CoV-2","enrollment":""},{"nctId":"NCT05095571","phase":"NA","title":"A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study","status":"RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-10-07","conditions":"Amyotrophic Lateral Sclerosis","enrollment":300},{"nctId":"NCT06593457","phase":"PHASE1","title":"A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Nurix Therapeutics, Inc.","startDate":"2024-08-20","conditions":"Healthy Volunteers","enrollment":32},{"nctId":"NCT06327295","phase":"PHASE2","title":"A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis","status":"RECRUITING","sponsor":"AmtixBio Co., Ltd.","startDate":"2024-07-01","conditions":"Onychomycosis","enrollment":120},{"nctId":"NCT06826716","phase":"NA","title":"A Study to Assess the Effect of Libifem® (VL-GF-01) on Fertility in Women With Diminished Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2025-02-10","conditions":"Female Fertility","enrollment":150},{"nctId":"NCT06672666","phase":"PHASE2","title":"Use of CBD in the Treatment of Anxiety","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-01-06","conditions":"Anxiety, Generalized Anxiety Disorder, Sleep Problems","enrollment":30},{"nctId":"NCT06249152","phase":"PHASE2","title":"Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2024-04-21","conditions":"Open-angle Glaucoma (OAG), Ocular Hypertension (OHT), Glaucoma","enrollment":36},{"nctId":"NCT06016972","phase":"PHASE2","title":"Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2024-03-05","conditions":"Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye","enrollment":63},{"nctId":"NCT05975047","phase":"PHASE1","title":"A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)","status":"COMPLETED","sponsor":"Liveome Inc.","startDate":"2023-09-24","conditions":"Ulcerative Colitis","enrollment":38},{"nctId":"NCT05946876","phase":"PHASE1","title":"A Phase 1 Study of XH-S003 in Healthy Volunteers","status":"COMPLETED","sponsor":"S-INFINITY Pharmaceuticals Co., Ltd","startDate":"2023-08-24","conditions":"Healthy","enrollment":77},{"nctId":"NCT04641975","phase":"PHASE3","title":"A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)","status":"TERMINATED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2021-03-15","conditions":"Overactive Bladder (OAB), Pharmacokinetics of Mirabegron","enrollment":26},{"nctId":"NCT03603795","phase":"PHASE2","title":"Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2018-10-11","conditions":"Acute Myeloid Leukemia","enrollment":110},{"nctId":"NCT06658717","phase":"NA","title":"A Study to Assess the Effect of the Natural Orange Extract in Individuals With Gastrointestinal Discomfort","status":"NOT_YET_RECRUITING","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2024-10-15","conditions":"Gut Health","enrollment":64},{"nctId":"NCT03747939","phase":"PHASE4","title":"Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.","status":"COMPLETED","sponsor":"Amgen","startDate":"2018-12-31","conditions":"Arthritis, Psoriatic","enrollment":310},{"nctId":"NCT04184882","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)","status":"TERMINATED","sponsor":"Astellas Pharma Inc","startDate":"2021-02-24","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":8},{"nctId":"NCT02771860","phase":"PHASE2","title":"RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-03","conditions":"Hand Osteoarthritis","enrollment":100},{"nctId":"NCT05941793","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients","status":"COMPLETED","sponsor":"Oneness Biotech Co., Ltd.","startDate":"2023-09-11","conditions":"Mild to Moderate COVID-19","enrollment":135},{"nctId":"NCT04915846","phase":"PHASE1, PHASE2","title":"Tamoxifen Therapy for Myotubular Myopathy","status":"TERMINATED","sponsor":"James Dowling","startDate":"2020-12-18","conditions":"X Linked Myotubular Myopathy","enrollment":6},{"nctId":"NCT06514586","phase":"PHASE3","title":"The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy","status":"NOT_YET_RECRUITING","sponsor":"Oxagon","startDate":"2024-09","conditions":"Vaginal Atrophy, Genitourinary Syndrome of Menopause, Vulvar Atrophy","enrollment":244},{"nctId":"NCT04811131","phase":"PHASE2","title":"Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo","status":"TERMINATED","sponsor":"Arcutis Biotherapeutics, Inc.","startDate":"2021-03-04","conditions":"Vitiligo","enrollment":114},{"nctId":"NCT06496893","phase":"NA","title":"A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.","status":"NOT_YET_RECRUITING","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2024-07-25","conditions":"Pre Diabetes, Type2 Diabetes Mellitus","enrollment":100},{"nctId":"NCT06472583","phase":"PHASE2","title":"Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer","status":"RECRUITING","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2024-04-11","conditions":"Breast Cancer","enrollment":78},{"nctId":"NCT05496205","phase":"PHASE1","title":"A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers","status":"COMPLETED","sponsor":"iN Therapeutics Co., Ltd.","startDate":"2020-09-30","conditions":"Osteoarthritis, Pain, Post Herpetic Neuralgia","enrollment":104},{"nctId":"NCT05212701","phase":"PHASE2","title":"To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer","status":"WITHDRAWN","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-04-19","conditions":"Fatigue, Locally Advanced or Metastatic Breast Cancer","enrollment":""},{"nctId":"NCT06391164","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis","status":"NOT_YET_RECRUITING","sponsor":"PHARMENTERPRISES LLC","startDate":"2024-04","conditions":"Cystitis","enrollment":280},{"nctId":"NCT05837754","phase":"NA","title":"A Study to Assess the Gut Health Effects of Oil Compound on Healthy Adults","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2023-04-04","conditions":"Gut Health","enrollment":102},{"nctId":"NCT05599282","phase":"PHASE2","title":"The Efficacy and Safety of an Amino Acid Supplement in Adults","status":"COMPLETED","sponsor":"ZandA Technologies, llc","startDate":"2022-10-26","conditions":"Insulin-Like Growth Factor I, Healthy","enrollment":120},{"nctId":"NCT05604690","phase":"PHASE1","title":"Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers","status":"COMPLETED","sponsor":"Intravacc B.V.","startDate":"2022-11-03","conditions":"COVID-19","enrollment":40},{"nctId":"NCT05807529","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Orient Europharma Co., Ltd.","startDate":"2022-11-03","conditions":"Osteoarthritis, Knee","enrollment":136},{"nctId":"NCT04197986","phase":"PHASE3","title":"Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations","status":"TERMINATED","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2020-03-11","conditions":"Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer","enrollment":39},{"nctId":"NCT05212818","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults","status":"TERMINATED","sponsor":"Techfields Inc","startDate":"2022-05-10","conditions":"COVID-19 Pneumonia","enrollment":19},{"nctId":"NCT01817959","phase":"PHASE3","title":"Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2012-10","conditions":"Islet Transplantation in Diabetes Mellitus Type 1","enrollment":51},{"nctId":"NCT04800315","phase":"PHASE2","title":"A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Celgene","startDate":"2021-05-14","conditions":"Dermatitis, Atopic, Eczema","enrollment":221},{"nctId":"NCT05793684","phase":"PHASE2","title":"AD816 Crossover Study","status":"COMPLETED","sponsor":"Apnimed","startDate":"2023-04-28","conditions":"OSA, Obstructive Sleep Apnea","enrollment":25},{"nctId":"NCT04084678","phase":"PHASE3","title":"A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH","status":"TERMINATED","sponsor":"United Therapeutics","startDate":"2021-01-20","conditions":"PAH, Pulmonary Hypertension, Hypertension","enrollment":10},{"nctId":"NCT05632783","phase":"PHASE3","title":"TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study","status":"WITHDRAWN","sponsor":"IBSA Institut Biochimique SA","startDate":"2023-12","conditions":"Knee Osteoarthritis","enrollment":""},{"nctId":"NCT06040372","phase":"PHASE1","title":"A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects","status":"COMPLETED","sponsor":"LG Chem","startDate":"2020-03-16","conditions":"Obese, Overweight, Healthy","enrollment":112},{"nctId":"NCT04250571","phase":"NA","title":"Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-03-06","conditions":"Test Anxiety","enrollment":177},{"nctId":"NCT05478278","phase":"PHASE1","title":"An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics","status":"COMPLETED","sponsor":"Usona Institute","startDate":"2022-06-22","conditions":"QTc Interval, Pharmacokinetics","enrollment":60},{"nctId":"NCT05958771","phase":"PHASE3","title":"The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E","status":"UNKNOWN","sponsor":"University of Chile","startDate":"2023-07-06","conditions":"Rotavirus Gastroenteritis","enrollment":5800},{"nctId":"NCT05547438","phase":"PHASE1","title":"Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults","status":"UNKNOWN","sponsor":"NeuroTrauma Sciences, LLC","startDate":"2023-04-28","conditions":"Acute Ischemic Stroke","enrollment":32},{"nctId":"NCT04405739","phase":"PHASE2","title":"The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)","status":"COMPLETED","sponsor":"Ridgeback Biotherapeutics, LP","startDate":"2020-06-16","conditions":"SARS-CoV 2","enrollment":71},{"nctId":"NCT04803708","phase":"PHASE1, PHASE2","title":"Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Technophage, SA","startDate":"2021-03-22","conditions":"Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection","enrollment":20},{"nctId":"NCT05318521","phase":"PHASE3","title":"RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Overseas Pharmaceuticals, Ltd.","startDate":"2021-12-10","conditions":"Degenerative Arthritis","enrollment":500},{"nctId":"NCT04949789","phase":"NA","title":"Pilot Study to Evaluate Efficacy of Botanical Extracts as Protein Amplifier for Skeletal Muscle Strength & Growth.","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2021-06-17","conditions":"Muscle Strength","enrollment":28},{"nctId":"NCT03170271","phase":"PHASE3","title":"A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-07-07","conditions":"Asthma","enrollment":660},{"nctId":"NCT05048121","phase":"NA","title":"RCT to Evaluate the Cosmetic Efficacy of Demo-cosmetic Active Ingredient CLS02021","status":"COMPLETED","sponsor":"Anbiome Labs LLC","startDate":"2021-07-24","conditions":"Overall Skin Appearance, Dry Skin; Eczema","enrollment":50},{"nctId":"NCT04853823","phase":"PHASE1","title":"A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB","status":"UNKNOWN","sponsor":"Hapten Sciences, Inc.","startDate":"2021-11-01","conditions":"Contact Dermatitis","enrollment":32},{"nctId":"NCT01814332","phase":"PHASE2","title":"Analyzing Female Trauma Exposed Responses to a Medication","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2010-01-01","conditions":"Stress Disorders, Post-traumatic","enrollment":128},{"nctId":"NCT04692506","phase":"NA","title":"Study Evaluating the Safety and Tolerability","status":"COMPLETED","sponsor":"BioGaia AB","startDate":"2021-01-05","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT04229394","phase":"PHASE1","title":"2ccPA Study in Patients With Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"Orient Europharma Co., Ltd.","startDate":"2018-02-13","conditions":"Osteoarthritis (OA) of the Knee","enrollment":40},{"nctId":"NCT04749784","phase":"NA","title":"Effects of Arterin Cholesterol for Reduction of Lipid Levels","status":"UNKNOWN","sponsor":"Perrigo CSCI","startDate":"2020-10-30","conditions":"Blood Cholesterol Lowers, LDL-C","enrollment":114},{"nctId":"NCT04714294","phase":"PHASE1","title":"Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers","status":"UNKNOWN","sponsor":"Newsoara Biopharma Co., Ltd.","startDate":"2020-09-08","conditions":"Healthy","enrollment":84},{"nctId":"NCT03823560","phase":"NA","title":"Performance and Safety of Class IIb MD Celegyn® in VVA","status":"UNKNOWN","sponsor":"Nathura S.p.A","startDate":"2019-09-24","conditions":"Vulvovaginal Atrophy","enrollment":96},{"nctId":"NCT04684771","phase":"NA","title":"Tolerance, Efficacy, revAlidation, Myostim","status":"COMPLETED","sponsor":"Alternativa International S.A","startDate":"2015-03-23","conditions":"Anterior Cruciate Ligament Rupture","enrollment":35},{"nctId":"NCT03833076","phase":"NA","title":"A New Class IIb MD in Proctological Disorders","status":"COMPLETED","sponsor":"Nathura S.p.A","startDate":"2019-08-22","conditions":"Proctological Disorders","enrollment":118},{"nctId":"NCT04444674","phase":"PHASE1, PHASE2","title":"COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2020-06-24","conditions":"Coronavirus","enrollment":2130},{"nctId":"NCT04555447","phase":"NA","title":"Gastrointestinal Tolerability to Agavins and Impact on Host-gut Microbiota-metabolism Interactions Modulation","status":"COMPLETED","sponsor":"Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad Irapuato","startDate":"2019-03-22","conditions":"Obesity, Healthy","enrollment":52},{"nctId":"NCT04293172","phase":"PHASE3","title":"Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2020-06-30","conditions":"Sickle Cell Disease","enrollment":""},{"nctId":"NCT02279160","phase":"PHASE2","title":"Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2014-12","conditions":"Pulmonary Arterial Hypertension","enrollment":61},{"nctId":"NCT03542786","phase":"NA","title":"Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic","status":"COMPLETED","sponsor":"AB Biotics, SA","startDate":"2017-12-18","conditions":"HIV, Premature Aging","enrollment":89},{"nctId":"NCT01890746","phase":"PHASE2","title":"A Safety and Efficacy Study of Eltrombopag in Subjects With AML","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-09-05","conditions":"Acute Leukaemia","enrollment":148}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":387,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["irinotecan + cisplatin","Irrinotecan, Cisplatin"],"phase":"phase_3","status":"active","brandName":"Placebo (IP)","genericName":"Placebo (IP)","companyName":"Centocor, Inc.","companyId":"centocor-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}